Harrison G Zhang, Arianna Dagliati, Zahra Shakeri Hossein Abad, Xin Xiong, Clara-Lea Bonzel, Zongqi Xia, Bryce W Q Tan, Paul Avillach, Gabriel A Brat, Chuan Hong, Michele Morris, Shyam Visweswaran, Lav P Patel, Alba Gutiérrez-Sacristán, David A Hanauer, John H Holmes, Malarkodi Jebathilagam Samayamuthu, Florence T Bourgeois, Sehi L'Yi, Sarah E Maidlow, Bertrand Moal, Shawn N Murphy, Zachary H Strasser, Antoine Neuraz, Kee Yuan Ngiam, Ne Hooi Will Loh, Gilbert S Omenn, Andrea Prunotto, Lauren A Dalvin, Jeffrey G Klann, Petra Schubert, Fernando J Sanz Vidorreta, Vincent Benoit, Guillaume Verdy, Ramakanth Kavuluru, Hossein Estiri, Yuan Luo, Alberto Malovini, Valentina Tibollo, Riccardo Bellazzi, Kelly Cho, Yuk-Lam Ho, Amelia L M Tan, Byorn W L Tan, Nils Gehlenborg, Sara Lozano-Zahonero, Vianney Jouhet, Luca Chiovato, Bruce J Aronow, Emma M S Toh, Wei Gen Scott Wong, Sara Pizzimenti, Kavishwar B Wagholikar, Mauro Bucalo, Tianxi Cai, Andrew M South, Isaac S Kohane, Griffin M Weber
The risk profiles of post-acute sequelae of COVID-19 (PASC) have not been well characterized in multi-national settings with appropriate controls. We leveraged electronic health record (EHR) data from 277 international hospitals representing 414,602 patients with COVID-19, 2.3 million control patients without COVID-19 in the inpatient and outpatient settings, and over 221 million diagnosis codes to systematically identify new-onset conditions enriched among patients with COVID-19 during the post-acute period...
June 29, 2022: NPJ Digital Medicine